Peng Jin
Xiaoyan Ji
Jingchao Bai3
Bin Ke
Yong Liu
Bin Wang- 1Department of Gastric Surgery, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Key Laboratory of Digestive Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- 2Department of Emergency Ward, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin, China
- 3Department of Gastrointestinal Cancer Biology, Tianjin Medical University Cancer Institute and Hospital, Key Laboratory of Cancer Immunology and Biotherapy, National Clinical Research Center for Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
- 4Department of Endoscopy, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, Tianjin, China
- 5Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, China
By Jin P, Ji X, Bai J, Su W, Ke B, Liu Y and Wang B (2025) Front. Immunol. 16:1622959. doi:
Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer
In the published article, there was an error in the Funding statement. The funder “Tianjin Key Medical Discipline (Specialty) Construction Project, TJYXZDXK-009A” was erroneously omitted. The correct Funding statement appears below.
“The author(s) declare that financial support was received for the research and/or publication of this article. This work was supported by grants from the Tianjin Key Medical Discipline (Specialty) Construction Project (TJYXZDXK-009A), Introduction of Talents and Doctoral Startup Fund (B2301 and B2320), The China Postdoctoral Science Foundation (2023M742618) and China National Postdoctoral Program for Innovative Talent (BX20240254).”
The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: gastric cancer, intratumoral microbiome, prognostic biomarkers, therapeutic responses, drug sensitivity, comprehensive analysis
Citation: Jin P, Ji X, Bai J, Su W, Ke B, Liu Y and Wang B (2025) Correction: Identification of prognosis and therapy related intratumoral microbiome and immune signatures in gastric cancer. Front. Immunol. 16:1670563. doi: 10.3389/fimmu.2025.1670563
Received: 21 July 2025; Accepted: 31 July 2025;
Published: 12 August 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Jin, Ji, Bai, Su, Ke, Liu and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Bin Wang, eWZ5d2syMDE0QDE2My5jb20=